Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New insights at the interface between leprosy and immune-mediated rheumatic diseases.
Cruz VA, de Albuquerque CP, Guimarães MFBR, Dionello CDF, Ribeiro SLE, de Souza VA, Gomes CM, da Mota LMH. Cruz VA, et al. Among authors: guimaraes mfbr. Front Med (Lausanne). 2023 Sep 25;10:1239775. doi: 10.3389/fmed.2023.1239775. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37822467 Free PMC article. Review.
Leptin as an obesity marker in rheumatoid arthritis.
Guimarães MFBR, de Andrade MVM, Machado CJ, Vieira ÉLM, Pinto MRDC, Júnior ALT, Kakehasi AM. Guimarães MFBR, et al. Rheumatol Int. 2018 Sep;38(9):1671-1677. doi: 10.1007/s00296-018-4082-5. Epub 2018 Jun 11. Rheumatol Int. 2018. PMID: 29947997
Predictors of serious infections in rheumatoid arthritis-a prospective Brazilian cohort.
de Almeida ALB, Guimarães MFBR, da Costa Pinto MR, Pereira LR, Reis APMG, Bonfiglioli KR, Louzada-Junior P, Giorgi RDN, de Castro GRW, Radominski SC, Brenol CV, Pugliesi A, da Mota LMH, da Rocha Castelar-Pinheiro G. de Almeida ALB, et al. Among authors: guimaraes mfbr. Adv Rheumatol. 2024 Mar 29;64(1):23. doi: 10.1186/s42358-024-00363-1. Adv Rheumatol. 2024. PMID: 38553751
Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.
Albuquerque CP, Reis APMG, Vargas Santos AB, Bértolo MB, Júnior PL, Neubarth Giorgi RD, Radominski SC, Guimarães MFBR, Bonfiglioli KR, L Cunha Sauma MF, Pereira IA, Brenol CV, Henrique Mota LM, Santos-Neto L, Castelar Pinheiro GR. Albuquerque CP, et al. Among authors: guimaraes mfbr. Adv Rheumatol. 2023 Apr 24;63(1):17. doi: 10.1186/s42358-023-00301-7. Adv Rheumatol. 2023. PMID: 37095556
Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.
Vicente GNS, Pereira IA, de Castro GRW, da Mota LMH, Carnieletto AP, de Souza DGS, da Gama FO, Santos ABV, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Guimarães MFBR, Bonfiglioli KR, Sauma MFLDC, Brenol CV, da Rocha Castelar Pinheiro G. Vicente GNS, et al. Among authors: guimaraes mfbr. Adv Rheumatol. 2021 Jun 25;61(1):38. doi: 10.1186/s42358-021-00186-4. Adv Rheumatol. 2021. PMID: 34172097
Real - rheumatoid arthritis in real life - study cohort: a sociodemographic profile of rheumatoid arthritis in Brazil.
Sacilotto NC, Giorgi RDN, Vargas-Santos AB, de Albuquerque CP, Radominski SC, Pereira IA, Guimarães MFBR, Bértolo MB, Louzada P Jr, Sauma MFLDC, Bonfiglioli KR, Brenol CV, da Mota LMH, Castelar-Pinheiro GDR. Sacilotto NC, et al. Among authors: guimaraes mfbr. Adv Rheumatol. 2020 Mar 14;60(1):20. doi: 10.1186/s42358-020-0121-5. Adv Rheumatol. 2020. PMID: 32171331
Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.
Guimarães MFBR, Pinto MRDC, Resende GG, Machado CJ, Vargas-Santos AB, Amorim RBC, Gomides APM, Albuquerque CP, Bértolo MB, Júnior PL, Santos IA, Giorgi RDN, Saciloto NC, Radominski SC, Borghi FM, Bonfiglioli KR, Silva HCD, Sauma MFLDC, Sauma ML, Medeiros JB, Pereira IA, Castro GRW, Brenol CV, Xavier RM, Mota LMH, Castelar-Pinheiro GDR. Guimarães MFBR, et al. PLoS One. 2020 Mar 13;15(3):e0230317. doi: 10.1371/journal.pone.0230317. eCollection 2020. PLoS One. 2020. PMID: 32168350 Free PMC article.
High Levels of Polypharmacy in Rheumatoid Arthritis-A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study.
Gomides APM, Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RD, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRC, Resende GG, Bonfiglioli KR, Carriço H, Sauma MFLC, Sauma ML, Medeiros JB, Pereira IA, Castro GRW, Brenol CV, Xavier RM, Mota LMH, Pinheiro GRC. Gomides APM, et al. Among authors: guimaraes mfbr. J Pharm Pract. 2021 Jun;34(3):365-371. doi: 10.1177/0897190019869158. Epub 2019 Aug 26. J Pharm Pract. 2021. PMID: 31451091
Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
Gomides APM, de Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RDN, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRDC, Resende GG, Bonfiglioli KR, Silva HCD, Sauma MFLDC, Sauma ML, de Medeiros JB, Pereira IA, de Castro GRW, Brenol CV, Xavier RM, da Mota LMH, Pinheiro GDRC. Gomides APM, et al. Among authors: guimaraes mfbr. PLoS One. 2019 Apr 4;14(4):e0215198. doi: 10.1371/journal.pone.0215198. eCollection 2019. PLoS One. 2019. PMID: 30947308 Free PMC article.
14 results